Published in Ann Rheum Dis on January 27, 2005
Methotrexate--how does it really work? Nat Rev Rheumatol (2010) 2.24
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis. Rheumatol Int (2014) 1.41
Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX. Rheumatology (Oxford) (2008) 0.92
Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. Arthritis Rheum (2011) 0.92
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. Pharmacogenomics J (2012) 0.92
Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand? Int J Rheumatol (2012) 0.90
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis. Pharmacogenomics (2015) 0.83
Identifying genomic and developmental causes of adverse drug reactions in children. Pharmacogenomics (2010) 0.83
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med (2013) 0.82
Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate. Hum Genomics Proteomics (2010) 0.81
Pharmacokinetics, pharmacodynamics and toxicities of methotrexate in healthy and collagen-induced arthritic rats. Biopharm Drug Dispos (2013) 0.81
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol (2016) 0.80
Pharmacogenetics and pharmacogenomics in rheumatology. Immunol Res (2013) 0.80
Low-dose methotrexate results in the selective accumulation of aminoimidazole carboxamide ribotide in an erythroblastoid cell line. J Pharmacol Exp Ther (2013) 0.79
[Methotrexate in rheumatology]. Z Rheumatol (2009) 0.79
Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis? Curr Rheumatol Rep (2010) 0.78
Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study. RMD Open (2017) 0.78
Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies. Pharmgenomics Pers Med (2010) 0.77
Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms. Biomed Res Int (2014) 0.77
Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients. Rheumatol Int (2010) 0.77
Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease. Cell Mol Immunol (2011) 0.76
Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis. J Pharm Health Care Sci (2016) 0.75
Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis. Sci Rep (2016) 0.75
Understanding Personalized Medicine in Rheumatoid Arthritis: A Clinician's Guide to the Future. Ther Adv Musculoskelet Dis (2009) 0.75
Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study. Arthritis Res Ther (2015) 0.75
Phase II trial of methotrexate in myasthenia gravis. Ann N Y Acad Sci (2012) 0.75
Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate. Arthritis Rheumatol (2014) 0.75
Towards personalized medicine - the role of methotrexate. Indian J Med Res (2011) 0.75
Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis. Pharmacogenomics J (2016) 0.75
The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis. Rheumatol Int (2013) 0.75
[The future of methotrexate therapy and other folate inhibitors]. Z Rheumatol (2011) 0.75
The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies--a systematic review. Eur J Clin Pharmacol (2015) 0.75
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab. RMD Open (2017) 0.75
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med (2000) 10.21
Pharmacogenomics--drug disposition, drug targets, and side effects. N Engl J Med (2003) 7.23
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med (1994) 3.53
Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med (1985) 3.37
Toward a better understanding of methotrexate. Arthritis Rheum (2004) 2.69
The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest (1993) 2.66
The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (1990) 2.59
Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum (1994) 2.32
Membrane transport of folates. Vitam Horm (2003) 2.25
The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum (1986) 2.12
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum (2001) 2.11
Polyglutamation of methotrexate. Is methotrexate a prodrug? J Clin Invest (1985) 2.06
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum (2004) 2.04
Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest (1998) 1.86
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis Rheum (2001) 1.68
Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? Ann Rheum Dis (2003) 1.59
Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. J Biol Chem (1985) 1.49
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC. Am J Hum Genet (2004) 1.30
The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol (1998) 1.19
Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet (2002) 1.17
Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Arthritis Rheum (2004) 1.11
Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet (2002) 1.11
The methotrexate therapeutic response in rheumatoid arthritis. J Rheumatol (2002) 1.03
Folate-induced remission in aplastic anemia with familial defect of cellular folate uptake. N Engl J Med (1978) 1.02
Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy. Arthritis Rheum (1987) 1.00
HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis. Clin Chem (2003) 0.98
Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. Mol Genet Metab (2003) 0.95
Pharmacogenetics in rheumatology: the prospects and limitations of an emerging field. Rheumatology (Oxford) (2002) 0.84
Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy. Arthritis Rheum (1989) 0.81
Ex nihilo nihil fit. Arthritis Rheum (2004) 0.78
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature (2000) 32.30
Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA (1998) 18.02
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (1995) 10.02
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis (2008) 6.97
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science (1999) 6.96
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
New centrifugation blood culture device. J Clin Microbiol (1978) 4.74
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet (1992) 4.10
Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U S A (1994) 3.95
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet (2009) 3.87
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Insertional mutagenesis of genes required for seed development in Arabidopsis thaliana. Genetics (2001) 3.49
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A (1999) 3.49
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Am J Physiol Endocrinol Metab (2008) 3.29
Public health implications of 1990 air toxics concentrations across the United States. Environ Health Perspect (1998) 3.18
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med (1999) 3.10
Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril (1986) 3.08
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum (2004) 3.00
Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA (2001) 2.93
Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol (1997) 2.80
Immunization with purified protein antigens from Streptococcus mutans against dental caries in rhesus monkeys. Infect Immun (1981) 2.72
A four-dimensional probabilistic atlas of the human brain. J Am Med Inform Assoc (2001) 2.64
Genetic studies on plasmid-linked cadmium resistance in Staphylococcus aureus. J Bacteriol (1972) 2.56
Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J (2005) 2.48
Vascular endothelial growth factor platelet counts, and prognosis in renal cancer. Lancet (1999) 2.26
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet (1998) 2.26
Physical exercise and psychological well being: a critical review. Br J Sports Med (1998) 2.25
Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol (2001) 2.23
The internal sphincter and Lord's procedure for haemorrhoids. Br J Surg (1975) 2.19
Metallothionein mRNA induction in HeLa cells in response to zinc or dexamethasone is a primary induction response. Nature (1980) 2.18
Carbonic anhydrase: new insights for an ancient enzyme. J Biol Chem (2001) 2.17
The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA (2000) 2.12
Uninfected avian cells contain RNA related to the transforming gene of avian sarcoma viruses. Cell (1978) 2.10
Absolute oral bioavailability of ciprofloxacin. Antimicrob Agents Chemother (1986) 1.97
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum (1998) 1.93
Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries. Infect Immun (1985) 1.92
Abnormal red-blood-cell morphology in myalgic encephalomyelitis. Lancet (1987) 1.92
Heart failure management programmes in Europe. Eur J Cardiovasc Nurs (2006) 1.89
Immunological and bacteriological basis for vaccination against dental caries in rhesus monkeys. Nature (1975) 1.89
Sequence organization of the beta-globin mRNA precursor. Nucleic Acids Res (1978) 1.89
Tackling organisational change in the new NHS. BMJ (2001) 1.88
Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases. Nature (1991) 1.88
Physical therapy episodes of care for patients with low back pain. Phys Ther (1994) 1.88
Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem (2000) 1.86
Sequence-tagged connectors: a sequence approach to mapping and scanning the human genome. Proc Natl Acad Sci U S A (1999) 1.85
Improving prevention systems in primary care practices: the Health Education and Research Trial (HEART) J Fam Pract (2000) 1.78
The biochemical pharmacology of abused drugs. II. Alcohol and barbiturates. Clin Pharmacol Ther (1974) 1.76
Cytoskeletal F-actin patterns quantitated with fluorescein isothiocyanate-phalloidin in normal and transformed cells. Proc Natl Acad Sci U S A (1980) 1.73
Increase in anterior tibialis muscle protein synthesis in healthy man during mixed amino acid infusion: studies of incorporation of [1-13C]leucine. Clin Sci (Lond) (1989) 1.72
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford) (2006) 1.71
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med (1983) 1.70
The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer (1990) 1.69
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis Rheum (2001) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Accuracy and completeness of recording of confirmed tuberculosis in two South African communities. Int J Tuberc Lung Dis (2011) 1.65
An immunological investigation into the prevention of caries in deciduous teeth of rhesus monkeys. Arch Oral Biol (1975) 1.65
Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr (1999) 1.63
Immunisation with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys. Lancet (1980) 1.61
Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex. Proc Natl Acad Sci U S A (1983) 1.60
A unique method of keeping the ear speculum steady. Clin Otolaryngol (2008) 1.59
Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis (2006) 1.59
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline [proceedings]. Br J Clin Pharmacol (1977) 1.55
The development of evidence-informed physical activity guidelines for adults with spinal cord injury. Spinal Cord (2011) 1.55
Ancient single origin for Malagasy primates. Proc Natl Acad Sci U S A (1996) 1.55
Behavioral and emotional problems among preschool children in pediatric primary care: prevalence and pediatricians' recognition. Pediatric Practice Research Group. Pediatrics (1993) 1.54
Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology (2000) 1.54
Symbolic description of intracerebral vessels segmented from magnetic resonance angiograms and evaluation by comparison with X-ray angiograms. Med Image Anal (2001) 1.53
Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer (1999) 1.53
Slowly fading super-luminous supernovae that are not pair-instability explosions. Nature (2013) 1.52
Changes in human muscle protein synthesis after resistance exercise. J Appl Physiol (1985) (1992) 1.52
Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. Curr Biol (2001) 1.51
Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry (2001) 1.51
Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med (2003) 1.50
Estimating cancer risk from outdoor concentrations of hazardous air pollutants in 1990. Environ Res (2000) 1.50
Metabolism of ( 14 C)methamphetamine in man, the guinea pig and the rat. Biochem J (1972) 1.48
Treatment of multiple cutaneous leiomyomas with CO2 laser ablation. Dermatol Surg (2000) 1.47
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Arthritis Rheum (1999) 1.47
An ultraviolet-optical flare from the tidal disruption of a helium-rich stellar core. Nature (2012) 1.47
Human infection due to recombinant vaccinia-rabies glycoprotein virus. N Engl J Med (2001) 1.45
Sexual disturbances arising from multiple sclerosis. Acta Neurol Scand (1984) 1.45
The isolation and partial characterization of recombinant DNA containing genomic globin sequences from the goat. J Biol Chem (1979) 1.44
Effect of malnutrition at the time of diagnosis on the survival of children treated for cancer in El Salvador and Northern Brazil. J Pediatr Hematol Oncol (2000) 1.44
Comparison of two porcine (Sus scrofa domestica) skin models for in vivo near-infrared laser exposure. Comp Med (2000) 1.43
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. Am J Med (1982) 1.42
Protein synthesis rates in human muscles: neither anatomical location nor fibre-type composition are major determinants. J Physiol (2004) 1.42
Personal names and the attentional blink: a visual "cocktail party" effect. J Exp Psychol Hum Percept Perform (1997) 1.42
Paediatric hanging associated out of hospital cardiac arrest in Melbourne, Australia: characteristics and outcomes. Emerg Med J (2011) 1.41
Trends in asthma mortality in New Zealand, 1908-1986. Med J Aust (1990) 1.41
Strength training effects in prepubescent boys. Med Sci Sports Exerc (1990) 1.41
Fibre mapping--a case study. Sci Justice (2004) 1.40